July 23, 2025
The National Stock Exchange of India LimitedExchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.
Scrip Code: STAR
The BSE LimitedPhiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001.
Scrip Code: 532531
Dear Madam/ Sir,
Sub: Intimation regarding Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Tuesday, July 29, 2025, to consider and approve the un-audited financial results (standalone and consolidated) of the Company for the quarter ended June 30, 2025, amongst other matters.
Further, as per provisions of the Company's Code of Conduct for Prohibition of Insider Trading, trading window for Designated Persons of the Company is closed from July 1, 2025 and shall open after 48 hrs post declaration of financial results by the Company.
The above information will also be available on website of the Company at https://www.strides.com.
This is for your kind information and record purposes. Thanks & Regards,
For Strides Pharma Science Limited,
MANJUL A R
Digitally signed by MANJULA R
Date: 2025.07.23
18:24:14 +05'30'
Manjula Ramamurthy Company Secretary & Compliance Officer ICSI Membership No.: A30515Strides Pharma Science Limited
CIN: L24230MH1990PLC057062
Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India Tel: +91-80-6784 0000 Fax: +91 80 6784 0700 Regd Off: 'Cyber One', Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703, India Tel:+91-22-2789 2924/ 3199corpcomm@strides.com; https://www.strides.com